ReviewVascular health and risk management2012

Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib.

Marta A Miyares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.